Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40021794
Localisation
France
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
14/08/2025
Statut
Classification
1.5°C
Année cible
2034
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target: Opella. commits to reach net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: Opella. commits to reduce absolute scope 1 and 2 GHG emissions 58.8% by 2034 from a 2023 base year. Opella. also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, upstream transportation and distribution, and business travel 58.8% within the same timeframe. Long-Term Targets: Opella. commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2050 from a 2023 base year. Opella. also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, fuel- and energy-related activities, upstream transportation and distribution, waste generated in operations, business travel, use of sold products, and end-of-life treatment of sold products 90% within the same timeframe.
Statut
Targets setAnnée cible
2050
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
Source : Science Based Targets initiative | Données publiques